Orchid Pharma Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20

Sales

819.37

665.90

556.97

450.70

505.45

Operating profit

110.68

83.62

57.26

57.89

-44.26

Interest

16.33

32.23

32.01

51.34

4.16

Gross profit

124.74

70.82

34.25

13.03

-23.94

EPS (Rs)

18.68

13.28

-1.18

-28.70

-16.84

Other income

30.39

19.43

9.00

6.48

24.49

Stock adjustment

-43.89

-21.48

-22.73

-15.69

5.83

Raw material

528.35

406.10

336.80

244.96

234.24

Power and fuel

-

-

-

-

-

Employee expenses

69.64

65.35

60.21

64.40

81.48

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

154.59

132.31

125.44

99.14

228.16

Provisions made

-

-

-

-

-

Depreciation

33.22

54.79

87.02

108.90

125.90

Taxation

-3.23

-

-

-

-

Net profit / loss

94.75

54.19

-4.81

-117.15

-149.84

Extra ordinary item

-

38.15

47.96

-21.28

-

Prior year adjustments

-

-

-

-

-

Equity capital

50.72

40.82

40.82

40.82

88.96

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

13.51

12.56

10.28

12.84

-8.76

GPM (%)

14.68

10.33

6.05

2.85

-4.52

NPM (%)

11.15

7.91

-0.85

-25.63

-28.27